Skip to main content
Fig. 3 | BMC Medicine

Fig. 3

From: Liquid biopsy posttreatment surveillance in endemic nasopharyngeal carcinoma: a cost-effective strategy to integrate circulating cell-free Epstein-Barr virus DNA

Fig. 3

Cost-effectiveness acceptability curves. The figure illustrates the acceptability of each surveillance strategy in the probabilistic sensitivity analysis for stage I (A), II (B), III (C), and IV (D) NPC patients. The curves in different colors illustrate the probability of each surveillance strategy being the most cost-effective at a given willingness-to-pay threshold. Abbreviations: BS, bone scintigraphy; cfEBV, cell-free Epstein-Barr virus; CT, computed tomography; MRI, magnetic resonance imaging; NPC, nasopharyngeal carcinoma; PET/CT, positron emission tomography/computed tomography; QALY, quality-adjusted life-year

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us